Related Experiment Video

Updated: Oct 25, 2025

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

9.6K

Oncolytic HSV: Underpinnings of Tumor Susceptibility

Chase Kangas1, Eric Krawczyk1, Bin He1

  • 1Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, IL 60612, USA.

Viruses
|August 10, 2021
PubMed

Insights

Oncolytic herpes simplex virus (oHSV) therapy shows promise for cancer treatment. Understanding how tumors suppress viral defenses, particularly nucleic acid sensing, is key to improving oHSV efficacy.

Area of Science:

  • Oncolytic virotherapy
  • Cancer biology
  • Immunology

Background:

  • Oncolytic herpes simplex virus (oHSV) is a promising cancer therapy.
  • oHSV efficacy relies on tumor cells' inability to limit viral replication.
  • Tumor cells often silence pathways that restrict viruses in healthy tissues.

Purpose of the Study:

  • To review the molecular mechanisms of tumor susceptibility to oHSV.
  • To focus on the role of malignant suppression of nucleic acid sensing.
  • To discuss strategies for enhancing oHSV clinical efficacy.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of tumor cell pathways involved in oHSV replication.
  • Examination of strategies to overcome viral resistance.

Main Results:

  • Tumor cells exploit mechanisms to evade immune responses against oHSV.
  • Malignant silencing of nucleic acid sensing pathways is critical for oHSV success.
  • Understanding these mechanisms informs the design of next-generation oHSV.

Conclusions:

  • Further research into tumor-oHSV interactions is needed.
  • Targeting nucleic acid sensing pathways can improve oHSV therapy.
  • Rational design of oHSV can enhance treatment outcomes for cancer patients.
Keywords:
STINGT-VECherpes simplex virusimmunotherapyinterferononcolytic virusvirotherapy

More Related Videos

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.0K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

12.9K

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K